Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization

CardioVascular and Interventional Radiology

Volumn 33, Issue 6, 2010, Pages 1143-1152

  Riaz, Ahsun ^a   Lewandowski, Robert J ^a   Kulik, Laura ^a   Ryu, Robert K ^a   Mulcahy, Mary F ^a   Baker, Talia ^a   Gates, Vanessa ^a   Nayar, Ritu ^a   Wang, Ed ^a   Miller, Frank H ^a   Sato, Kent T ^a   Omary, Reed A ^a   Abecassis, Michael ^a   Salem, Riad ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Hepatocellular cancer; Imaging; Radiologic pathologic correlation; Transarterial chemoembolization

Indexed keywords

CISPLATIN; DOXORUBICIN; GADOLINIUM; IODINATED POPPYSEED OIL; MITOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CONTROL; CANCER SIZE; CHEMOEMBOLIZATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE COURSE; EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER; FEMALE; FOLLOW UP; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR NECROSIS; WORLD HEALTH ORGANIZATION;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECROSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 78649318571     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-009-9766-5     Document Type: Article

References (30)

1. HB El-Serag 2002 Hepatocellular carcinoma and hepatitis C in the United States Hepatology 36 5 suppl 1 S74 S83 10.1002/hep.1840360710 12407579
2. V Mazzaferro E Regalia R Doci, et al. 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699 1:STN:280:DyaK287nsFWltw%3D%3D 10.1056/NEJM199603143341104 8594428
3. YK Maddala L Stadheim JC Andrews, et al. 2004 Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization Liver Transpl 10 449 455 10.1002/lt.20099 15004776
4. LM Kulik B Atassi L van Holsbeeck, et al. 2006 Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation J Surg Oncol 94 572 586 1:CAS:528:DC%2BD28XhtlCisb3P 10.1002/jso.20609 17048240
5. DS Lu NC Yu SS Raman, et al. 2005 Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver Radiology 234 954 960 10.1148/radiol.2343040153 15681691
6. JF Geschwind D Artemov S Abraham, et al. 2000 Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis J Vasc Interv Radiol 11 1245 1255 1:STN:280:DC%2BD3Mzgs1ehtw%3D%3D 10.1016/S1051-0443(07)61299-8 11099235
7. IR Kamel DA Bluemke D Ramsey, et al. 2003 Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma AJR Am J Roentgenol 181 708 710 12933464
8. JM Llovet AM Di Bisceglie J Bruix, et al. 2008 Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 698 711 10.1093/jnci/djn134 18477802
9. SJ Hunt W Yu J Weintraub MR Prince N Kothary 2009 Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation J Vasc Interv Radiol 20 30 38 10.1016/j.jvir.2008.09.034 19028117
10. TA Waldmann JD White JA Carrasquillo, et al. 1995 Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac Blood 86 4063 4075 1:CAS:528:DyaK2MXpslaku70%3D 7492762
11. J Bruix M Sherman JM Llovet, et al. 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 430 1:STN:280:DC%2BD3MrksFCmtg%3D%3D 10.1016/S0168-8278(01)00130-1 11592607
12. A Forner C Ayuso M Varela, et al. 2009 Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115 616 623 10.1002/cncr.24050 19117042
13. HB El-Serag JA Marrero L Rudolph KR Reddy 2008 Diagnosis and treatment of hepatocellular carcinoma Gastroenterology 134 1752 1763 10.1053/j.gastro.2008. 02.090 18471552
14. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236 10.1002/hep.20933 16250051
15. JM Llovet J Fuster J Bruix 2004 The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma Liver Transpl 10 2 suppl 1 S115 S120 10.1002/lt.20034 14762851
16. A Riaz L Kulik RJ Lewandowski, et al. 2009 Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres Hepatology 49 1185 1193 10.1002/hep.22747 19133645
17. S Katyal JH Oliver 3rd MS Peterson JV Ferris BS Carr RL Baron 2000 Extrahepatic metastases of hepatocellular carcinoma Radiology 216 698 703 1:STN:280:DC%2BD3cvktVantA%3D%3D 10966697
18. DM Coldwell KR Stokes WF Yakes 1994 Embolotherapy: agents, clinical applications, and techniques Radiographics 14 623 643 1:STN:280: DyaK2czksFWqsg%3D%3D 8066276
19. T Nakashima M Kojiro 1986 Pathologic characteristics of hepatocellular carcinoma Semin Liver Dis 6 259 266 1:STN:280:DyaL2s%2Fkt1ymtw%3D%3D 10.1055/s-2008-1040608 3022387
20. J Bruix M Sala JM Llovet 2004 Chemoembolization for hepatocellular carcinoma Gastroenterology 127 5 suppl 1 S179 S188 1:CAS:528: DC%2BD2cXhtVGmtb%2FF 10.1053/j.gastro.2004.09.032 15508083
21. R Salem KG Thurston 2006 Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction J Vasc Interv Radiol 17 1571 1593 10.1097/01.RVI.0000236744.34720.73 17056999
22. K Takayasu S Arii I Ikai, et al. 2006 Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 461 469 1:CAS:528:DC%2BD28XpsFyks7Y%3D 10.1053/j.gastro.2006.05.021 16890600
23. IR Kamel DA Bluemke J Eng, et al. 2006 The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma J Vasc Interv Radiol 17 505 512 10.1097/01.RVI. 0000200052.02183.92 16567675
24. M De Santis S Alborino PL Tartoni P Torricelli A Casolo R Romagnoli 1997 Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization Eur Radiol 7 10 16 10.1007/s003300050099 9000387
25. H Yoshioka K Nakagawa H Shindou, et al. 1990 MR imaging of the liver before and after transcatheter hepatic chemo-embolization for hepatocellular carcinoma Acta Radiol 31 63 67 1:STN:280:DyaK3c3ltl2ksQ%3D%3D 2160264
26. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10.1093/jnci/92.3.205 10655437
27. HL Marin EE Furth K Olthoff A Shaked MC Soulen 2009 Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma J Gastrointestin Liver Dis 18 169 176 19565046
28. A Veltri M Grosso MC Martina, et al. 1998 Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study Cardiovasc Intervent Radiol 21 393 398 1:STN:280:DyaK1M%2FntVamtQ%3D%3D 10.1007/s002709900286 9853145
29. DS Lu NC Yu SS Raman, et al. 2005 Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation Hepatology 41 1130 1137 10.1002/hep.20688 15841454
30. JM Llovet MI Real X Montana, et al. 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 9319 1734 1739 10.1016/S0140-6736(02)08649-X 12049862